Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
Becher
R
R
Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, Federal Republic of Germany.
Kloke
O
O
Höffken
K
K
Scheulen
M E
ME
Wandl
U B
UB
Bojar
H
H
Schmidt
C G
CG
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008545:Melanoma / Q000188:drug therapy*
D000970:Antineoplastic Agents; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone